Orion PharmaDHA:ORIONPHARM +1.41%69 Quick Ratio is 1.93 as of Mar. 2026, which is 2% above its 10-year median of 1.89. GuruFocus rates DHA:ORIONPHARM with a GF Score™ of 69/100 and a GF Value™ of BDT20.38 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 445 Utilities - Independent Power Producers companies, Orion Pharma ranks better than 70.79% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Orion Pharma's quick ratio for the quarter that ended in Mar. 2026 was 1.93.
Orion Pharma has a quick ratio of 1.93. It generally indicates good short-term financial strength.
The historical rank and industry rank for Orion Pharma's Quick Ratio or its related term are showing as below:
DHA:ORIONPHARM'
s Quick Ratio Range Over the Past 10 Years
Min: 1.36 Med: 1.89 Max: 3.88
Current: 1.93
During the past 12 years, Orion Pharma's highest Quick Ratio was 3.88. The lowest was 1.36. And the median was 1.89.
DHA:ORIONPHARM's Quick Ratio is ranked better than 70.79% of 445
companies
in the Utilities - Independent Power Producers industry
Industry Median: 1.24
vs DHA:ORIONPHARM: 1.93
Orion Pharma (DHA:ORIONPHARM) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Orion Pharma Quick Ratio Related Terms
Orion Pharma Quick Ratio Historical Data
* Premium members only.
The historical data trend for Orion Pharma's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DHA:ORIONPHARM vs CEG, VST, NRG: Quick Ratio Comparison
For the Utilities - Independent Power Producers subindustry, Orion Pharma's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Orion Pharma Quick Ratio vs Utilities - Independent Power Producers Industry
For the Utilities - Independent Power Producers industry and Utilities sector, Orion Pharma's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Orion Pharma's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Orion Pharma's Quick Ratio for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Orion Pharma (DHA:ORIONPHARM) has a Quick Ratio of 1.93 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Orion Pharma and its competitors. This is near median its historical median of 1.89. Over the past decade, Orion Pharma's Quick Ratio has ranged from 1.36 to 3.88. According to the industry distribution chart, Orion Pharma ranks #130 out of 445 companies in the Utilities - Independent Power Producers industry, placing it in the top 29.2%.
Is Orion Pharma's Quick Ratio too high?
Orion Pharma's current Quick Ratio of 1.93 is near median its 10-year median of 1.89. Over the past 10 years, this metric has ranged from a low of 1.36 to a high of 3.88. The Utilities - Independent Power Producers industry median Quick Ratio is 1.24. Orion Pharma's value of 1.93 is 55.6% above this industry median. Based on the distribution chart, Orion Pharma ranks #130 out of 445 companies in the Utilities - Independent Power Producers industry, which is above the industry midpoint. Overall, Orion Pharma has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Orion Pharma's Quick Ratio compare to CEG and VST?
According to the Utilities - Independent Power Producers industry distribution chart, Orion Pharma ranks #130 out of 445 companies for Quick Ratio. This puts Orion Pharma in the upper half of its industry. The industry median Quick Ratio is 1.24. Orion Pharma's value of 1.93 is 55.6% above this benchmark. Historically, Orion Pharma's own Quick Ratio has ranged from 1.36 to 3.88 over the past decade. While the company's 10-year median is 1.89 vs. the industry median of 1.24, Orion Pharma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for an Utilities - Independent Power Producers company?
The median Quick Ratio among Utilities - Independent Power Producers companies is 1.24, based on 445 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Orion Pharma's current Quick Ratio of 1.93 is 55.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Orion Pharma and its competitors. For the Utilities - Independent Power Producers industry, the median Quick Ratio is 1.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Orion Pharma's current Quick Ratio is 1.93, which is near median its own 10-year median of 1.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orion Pharma stock overvalued right now?
Based on GuruFocus' analysis, Orion Pharma (DHA:ORIONPHARM) is currently considered Significantly Overvalued. The stock's GF Value™ is BDT20.38, compared to a current price of BDT28.80 — trading 41.3% above its estimated fair value. The current Quick Ratio is 1.93, which is near median its 10-year median of 1.89 and 55.6% above the Utilities - Independent Power Producers industry median of 1.24. Orion Pharma's overall GF Score™ is 69/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Orion Pharma (DHA:ORIONPHARM), the current Quick Ratio is 1.93 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Orion Pharma (DHA:ORIONPHARM) Overvalued in 2026?
Based on GuruFocus' analysis, Orion Pharma stock appears to be overvalued.
The current stock price of BDT28.80 is trading 41.3% above its estimated GF Value™ of BDT20.38.
GuruFocus considers Orion Pharma to be Significantly Overvalued.
Key valuation signals for DHA:ORIONPHARM:
Quick Ratio: 1.93 (near median its 10-year median of 1.89)
GF Value™: BDT20.38 vs. price of BDT28.80 (41.3% above fair value)
Industry Position: 55.6% above the Utilities - Independent Power Producers median (#130 of 445)
No single metric tells the full story. See the DHA:ORIONPHARM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Orion Pharma Ltd is a pharmaceutical company engaged in the creation and discovery, development, manufacturing, and marketing of pharmaceutical products, including vaccines and health-related consumer products. The company produces diversified dosage forms such as tablets, capsules, syrups, solutions, suspensions, powder for suspensions, creams, ointments, and injections under therapeutic categories including cardiovascular, antiulcerant, antiasthmatic, antihistamine, NSAIDs, antibiotic, antifungal, laxatives, anticancer, vitamins, and minerals. In addition, the company is involved in power generation activities and generates maximum revenue from pharmaceutical activities. The group principally carries out its business operations and markets its products in Bangladesh.
69GF Score
Get the complete analysis for DHA:ORIONPHARM
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:ORIONPHARM has been successfully added to your 
